HDL Cholesterol Kits Market Expanding at a healthy 4.8% CAGR, the market size is projected to total US$ 786.2 Mn by 2029

The growth of the HDL cholesterol kits market can be attributed to the increasing prevalence of atherosclerosis due to high cholesterol level, which favours the demand for cholesterol testing. According to the latest research by FMI, the global HDL cholesterol kits market is expected to be valued at US$ 786.2 Mn by the end of 2029. The HDL cholesterol kits market is expected to expand at a CAGR of 4.8% during the forecast period 2022-2029.

The increasing incidence of obesity and hyperlipidaemia among people is boosting the need for cholesterol testing, which is driving the growth of the HDL cholesterol kits market. The prevalence of obesity has increased from 33.7% in 2007-2008 to 39.7% in 2015-2016 among adults in the U.S. The increasing prevalence of obesity also increases the risk of cardiovascular disorders, high blood pressure, and hyperlipidaemia.

Moreover, the prevalence of hyperlipidaemia is high among the obese population. Nearly 60-70% of patients suffering from obesity have hyperlipidaemia. Other factors, such as growing awareness programs for cholesterol testing and growing cholesterol testing among diabetic patients, are also propelling the growth of the HDL cholesterol kits market.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9842

Rise of ‘Regular Health Check’ Trend Uplifts Prospects in East Asia

Low awareness in middle- and low-income countries about cholesterol testing and other healthcare testing are also among the major factors that are expected to hamper the growth of the HDL cholesterol kits market.

There is low awareness about diseases such as dyslipidaemia and hypercholesterolemia in middle-income countries and rural areas. Moreover, the chances of errors and inaccuracy in HDL cholesterol testing methods, such HDL cholesterol precipitating method, are among factors expected to restrain the growth of the HDL cholesterol kits market.

The North America HDL cholesterol kits market gain a maximum value share in 2021. However, the East Asia HDL cholesterol kits market expected to witness prominent growth owing to the higher demand for cholesterol testing in countries such as China and Japan.

Developing countries, such as China and India, represent a significant growth rate in the HDL cholesterol kits market due to the growing adoption of regular healthcare testing. The Middle East & Africa HDL cholesterol kits market is expected to witness a sluggish growth rate as compared to other regions.

The global HDL cholesterol kits market has been studied based on the product type and end user. Based on the product type, the HDL cholesterol kits market has been segmented into HDL cholesterol precipitating reagent kit, HDL cholesterol direct reagent kit, and HDL and LDL/VLDL assay kit.

The HDL and LDL/VLDL assay kit product type segment is expected to hold a prominent share in the global HDL cholesterol kits market. Based on end user, the HDL cholesterol kits market has been segmented into hospitals, clinics, and diagnostic laboratories. In terms of revenue, the hospitals segment of the HDL cholesterol kits market was a significant market for HDL cholesterol kits in 2021.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9842

Partnerships and Acquisitions Governing the Competition Landscape

Some of the key players operating in the HDL cholesterol kits market are Diazyme Laboratories, Inc., Randox Laboratories Limited, Fujifilm Holding Corporation, Thermo Fisher Scientific, Abcam plc., Merck KGaA, Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc.), PerkinElmer, Inc., and Hoffmann-La Roche Ltd.

Players in the HDL cholesterol kits market are focusing on partnerships and acquisitions with regional and global players to increase their sales worldwide. For instance, through the acquisition of Wako Pure Chemical, Fujifilm Holding Corporation expand its presence in the life science and chemical sectors.

The manufacturers of HDL cholesterol kits are focusing on the expansion of their presence in key markets such as the Asia Pacific, the Middle East, and Europe through distribution agreements and the opening of new manufacturing facilities.

The manufacturers of HDL cholesterol kits are also focusing on the development of point-of-care testing as it is more helpful and convenient for making quicker decisions. Moreover, HDL cholesterol kits industry stakeholders are focusing on the addition of direct reagent kits in their product portfolios

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/9842

HDL Cholesterol Kits Market by Category

Product Type:

  • HDL Cholesterol Precipitating Reagent Kit
  • HDL Cholesterol Direct Reagent Kit
  • HDL and LDL/VLDL Assay Kit

End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories

Region:

  • North America
  • Latin America
  • Europe
  • Oceania
  • East Asia
  • South Asia
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

 

Contact Us:

Future Market Insights
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedInTwitterBlogs

 

For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries:
press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Deflectable Catheters Market is projected to expand at a CAGR of 3.9% from 2022 to 2029

Deflectable catheters are used for minimally invasive procedures such as coronary interventions and electrophysiology applications. Due to the upgradation of technology, the core tip can deflect at a certain angle. According to the latest research by FMI, the global deflectable catheters market is expected to account for more than US$ 2,400.0 Mn in terms of value by the end of 2029. The deflectable catheters market report also projects a significant growth potential in the market with a CAGR of ~ 4% during the forecast period.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5852
Companies Eyeing Untapped Opportunities in Cost-sensitive Regional Markets

The current adoption pattern among healthcare professionals favour the use of reposable medical devices, a trend that is most certainly observed in developing countries, to complement the cost factor and availability. In contrast, most of the deflectable catheters used are one-time use products. Factors like blood, debris prevent using reposable deflectable catheters in operations as critical as electrophysiology.

The usage of reposable deflectable catheters is significantly higher in developing economies with inadequate resources, where the cost of treatment can be significantly high, which is unfavourable for patients from poor backgrounds. The present cost structure with the use of reposable deflectable catheters makes it feasible for a sizeable population to opt for low-cost treatment options, which help boost the adoption rate, and thereby expand the consumer pool.

At present, there are only a few companies offering reposable deflectable catheters, and none of the major players are into developing reposable devices. As per the report, a comparatively smaller company, CathRx, has a similar reposable product, Khelix, which is considered to be the first ‘reposable’ diagnostic and therapeutic catheter for the treatment of cardiac arrhythmias.

Acquisitions & Collaborations Playing Decisive Role in Shaping Deflectable Catheters Market Structure

The affective adjustments and development observed in the parent market influences the deflectable catheters market. The recent trend of involving digital methods for diagnosing cardiac problems is also changing the treatment pattern. All these trends are more governed by the top market leaders in the cardiology market. With abundant resources and investment plans, they manipulate the industry in a way in which no other smaller or regional manufacturer is capable of keeping pace with them.

The trend of acquisition and forming a strategic partnership is positive delivering financial results. For example, Abbott’s acquisition of St. Jude Medical resulted in the consolidation of the 2nd and 4th largest cardiology market players. Moreover, the acquisition of specific treatment technologies has also been observed in the deflectable catheter market, and there has been an increase in the number of players expanding their product portfolio for the treatment of atrial fibrillation/atrial flutter.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5852

Deflectable Catheters Market: Segmental Analysis

On the basis of product type, the deflectable catheters market has been segmented into uni-directional deflectable catheters, bi-directional deflectable catheters, and multi-directional deflectable catheters. Bi-directional deflectable catheters lead the market due to their high adoption rate and availability.

Based on application, the deflectable catheters market has been segmented into coronary interventions, electrophysiology, diagnostics imaging, and peripheral interventions. In terms of revenue, the electrophysiology segment is expected to have a major share in the deflectable catheters market due to an increase in the number of procedures being carried out by deflectable catheters.

On the basis of end user, the deflectable catheters market has been categorised into hospitals, office-based clinics, ambulatory surgical centres, and independent catheterisation labs. Independent catheterisation labs are expected to witness significant growth, which is driven by an increase in the number of the same.

Some of the key players in the deflectable catheters market include Medtronic Plc, Merit Medical Systems, JOHNSON & JOHNSON, Teleflex Incorporated, Boston Scientific Corporation, Biomerics LLC, OSYPKA AG, Abbott, Japan Lifeline Co., CathRx Ltd., and Biotronik SE & Co. KG.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-5852

HDL Cholesterol Kits Market by Category

Product Type:

  • HDL Cholesterol Precipitating Reagent Kit
  • HDL Cholesterol Direct Reagent Kit
  • HDL and LDL/VLDL Assay Kit

End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories

Region:

  • North America
  • Latin America
  • Europe
  • Oceania
  • East Asia
  • South Asia
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedInTwitterBlogs

 For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries:
press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Surgical Booms Market is projected to grow at a moderate CAGR of 4.7% between 2022 and 2029

Surgical booms are also known as Equipment Management Systems (EMS). Surgical booms are used to constrain electrical wiring from the various equipment used in the OR. They also help organise the space in the OR by increasing the working space. Most surgical booms are suspended from the roof of the OR and are available in a number of designs and utilities.

According to the latest research by FMI, the global surgical booms market is expected to account for more than US$ 380.2 Million in terms of value by the end of 2029. The surgical booms market report also projects significant growth potential with an anticipated average Y-o-Y growth rate of over 4.7% during the forecast period.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4375

Increase in the Adoption of Minimally Invasive Surgeries is Likely to Drive the Growth of the Surgical Booms Market

Minimally Invasive Surgery (MIS) is one of the major trends in medicine. MIS is a safe, feasible, and patient-friendly method of performing medical procedures such as surgery. MIS offers reduced postoperative pain, shorter length of stay in a hospital, lesser scarring or damage to tissues, and generally leads to faster recovery. Hence, MIS is easier and less time-consuming.

As clinicians seek safer and more efficient ways to perform surgery, they find new applications for minimally invasive procedures, because the benefits of the same for patients are paramount. Furthermore, the increasing number of insurance providers that offer reimbursement for costs incurred during most minimally invasive procedures is expected to increase the adoption rate of minimally invasive surgeries.

The Centers for Medicare and Medicaid Services (CMS) provides reimbursement for peripheral access procedures, such as the insertion of a port or catheter into a large central artery that is directly related to or is near the heart. Thus, increase in the number of minimally invasive surgeries is boosting the demand for equipment management systems such as equipment booms.

High Capital Investment for Integrated OR to Hinder the Growth of Surgical Booms Market

Integrated ORs utilise a crossover of medical interventions to form hybrid technologies. The development and integration of ORs requires the re-organization of professionals. In addition, there is a need to upgrade the capital equipment. Cost of such advanced capital equipment is high.

Furthermore, compatibility with existing or new devices/infrastructure is likely to present a hurdle for the designers, manufacturers, and end users of surgical booms. A hybrid OR, on an average, requires 50-80% more space as compared to a conventional OR in the U.S., and 30-40% more in Germany.

The additional space required is another factor that is likely to increase the cost of the setup of an integrated OR. Thus, the capital cost required for an integrated OR is likely to hinder the growth of the surgical booms market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4375

Surgical Booms Market: Segmental Analysis

The global surgical booms market has been segmented on the basis of product, installation, and end user. On the basis of product type, the surgical booms market has been segmented into equipment booms, utility booms, anaesthesia booms, and custom booms. Custom booms lead the market due to the flexibility of choice the customers have from manufacturers.

Based on installation, the surgical booms market has been segmented into roof mounting and floor mounting. In terms of revenue, the roof mounting segment is expected to have a major share in the surgical booms market during the forecast period as these are more flexible and conserve space in the OR more effectively.

On the basis of end user, the surgical booms market has been categorised into hospitals, ambulatory surgical centres, specialty clinics, and hybrid operating rooms. The revenue generated by the hospitals segment of the surgical booms market is expected to witness significant growth, which is driven by the presence of a large number of ORs and associated ICU departments at various hospitals.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/4375

Surgical Booms Market: Companies

Some of the key players in the surgical booms market include CV Medical LLC., Stryker Corporation, Hill Rom Holdings Inc., Amico Group of Companies, Steris Plc, Ondal Medical Systems GmbH, Getinge Group, Pratibha Medinox, Skytron LLc, and Palakkad Surgical Industries, among others.

Surgical Booms Market by Category

By Product:

  • Equipment Booms
  • Utility Booms
  • Anesthesia Booms
  • Custom Booms

By End User;

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Hybrid Operating Rooms

By Installation:

  • Roof Mounting
  • Floor Mounting

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedInTwitterBlogs

For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries:
press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Gene Editing Tools Market Expanding at a healthy 18.8% CAGR, the market size is projected to total US$ 1.6 Bn by 2029

According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 481.3 Mn in terms of value in 2022. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18.8% during the period 2022-2029.

The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9) segment is a leading segment in terms of revenue by product type in the gene editing tools market, and accounted for an approximate revenue share of 75% in 2018. CRISPR/Cas9 gene editing tools are most widely used by scientists to create transgenic animals that include zebrafish, pigs, mice, rats, and primates. Among all the distribution channels in the gene editing tools market, the academic and research institutes segment is expected to be most prominent segment, followed by biotech and pharmaceutical companies.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9544
Prevalence of Cancers and Rare Genetic Diseases Establish a Strong Base for Innovation of Gene Editing Tools

The rising prevalence of cancer and other genetic disorders, such as sickle cell disease, heart disease, diabetes, Alzheimer’s disease, obesity, and others, is among the key factors impacting the growth of gene editing tools market. Cancer is registered to be the second most prominent cause of death worldwide. According to the World Health Organization (WHO), the number of deaths due to cancer worldwide in 2015 was 8.8 million. However, cancer alone was responsible for an estimated 9.6 million deaths globally in 2021.

Worldwide, approximately about 1 in 6 deaths occur owing to cancer. An analysis states that approximately 70% of deaths due to cancer occur in low- and middle-income countries. Thus, gene editing is most preferred for the management of rare genetic disorders, which is driving the demand for gene editing, thus generating a favourable revenue opportunity for gene editing tools.

The growing prevalence and incidence of rare genetic disorders, majorly Sickle Cell Disease (SKD), cancer, and Alzheimer’s disease, is leading to the high demand for genome editing, and is one of the leading factors that is contributing significantly to the growth of the gene editing tools market. Moreover, gene editing tools, such as CRISPR, TALENs, and ZFNs, find precise applications in the treatment of cancer. Owing to the high efficiency and accuracy of the CRISPR-Cas9 gene editing technique, it has emerged as a potential tool for cancer therapy. Among its various applications, CRISPR-Cas9 has a high clinical potential to detect novel target genes for cancer therapy.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9544

Biomedical Community Eyes Potential Application of Gene Editing Tools

Introduction of technologically advanced gene editing tools is expected to boost the growth of gene editing tools market. Recent advancements in CRISPR gene editing tools and their ease of use have generated significant interest in the biomedical community. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based gene editing has high potential to cater to the therapeutic landscape of induced disorders, owing to the presence of key players in the industry such as Intellia, CRISPR Therapeutics, and Editas. CRISPR gene editing tools offer precise gene-targeted treatments for β-thalassemia and SKD. Among gene editing tools, there are potential applications for CRISPR in the gene editing tools market in human therapeutics as well as veterinary therapeutics.

Regional Players Focusing on Product Reach & Connectivity

North America, followed by Europe, is a prominent region in the global gene editing tools market. North America accounts for a revenue share of about 25.0% in 2021 in gene editing tools market. Europe accounting for the second-largest revenue share, and is followed by South Asia in the gene editing tools market. India, China, and Japan are among the emerging markets in the gene editing tools market. Japan is among the fastest-growing emerging markets in the global gene editing tools market, and is projected to grow at a CAGR of more than 6% during the forecast period of 2022-2028.

The gene editing tools market report tracks some of the key companies operating in gene editing tools market, such as Thermo Fisher Scientific Inc., ERS Genomics, CRISPR THERAPEUTICS, Merck KGaA, Editas Medicine, Takara Bio USA, New England Biolabs, Intellia Therapeutics, Inc., and GenScript Biotech Corporation. Majority of the key regional players in the gene editing tools market are focused on increasing their product reach and connectivity with the help of domestic distributors of gene editing tools. Moreover, the manufacturers of gene editing tools are focused to strengthening their businesses in high-growth markets, such as India, Japan, China, and Argentina, by expanding their sales and distribution channels across these countries.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-9544

Gene Editing Tools Market by Category

BY Product:

  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9)
  • Zinc Finger Nucleases (ZFNs)
  • Transcription Activator-Like Effector Nucleases (TALENs)
  • Viral Systems
  • Transposon Systems
  • Others

BY Application:

  • Veterinary Medicine
  • Cell Line Engineering
  • Bioremediation
  • Food and Brewing Development
  • Food Waste Management
  • Bio sensing Development
  • Others

BY End User:

  • Biotech and Pharma Companies
  • Contract Research Organizations
  • Academic and Research Institutes
  • Food Industry
  • Others

BY Region:

  • North America
  • Latin America
  • Europe
  • Oceania
  • East Asia
  • South Asia
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedInTwitterBlogs

 

For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries:
press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Mucopolysaccharidosis (MPS) Treatment Market is projected to grow at a robust CAGR of 5.9% between 2022 and 2029

A market study presented by FMI ‘ Mucopolysaccharidosis Treatment Market is estimated to be worth around US$ 2.38 Bn in 2022 at a robust CAGR of 5.9% between 2022 and 2029

According to research, the mucopolysaccharidosis treatment is still emerging, and different geographies have implemented standard treatment options for the condition. However, there is no universally accepted treatment pattern for mucopolysaccharidosis. Mucopolysaccharidosis falls under rare diseases, which is a complex, diverse, constantly evolving field, and there is a significant shortage of medical and scientific data related to it. Mucopolysaccharidosis treatment and diagnosis involves complex managing requirements, which include long-term care, rehabilitation support, and a continuous treatment plan.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5880

Research Activities Uplift Stem Cell Therapy Application in MPS Treatment

In the present scenario, the drugs that are considered for mucopolysaccharidosis treatment, such as aldurazyme, naglazyme, vimizim, elaprase, mepsevii and hunterase, are the only regulated and recommended drugs present in the market. These drugs fall under enzyme replacement therapies, however, with present research initiatives for stem cell therapies, the latter is considered a prominent mucopolysaccharidosis treatment. Clinical research shows that stem cell transplantation covers a large area that is not covered with the more frequently recommended practice of enzyme replacement therapies, which changes the current market structure for mucopolysaccharidosis treatment, prioritising the latter.

Stem cell therapy is a therapeutic option for mucopolysaccharidosis patients suffering from a severe phenotype, as research shows the method can preserve neurocognition or can even help break the progressive neurodegeneration. The method is provided with strict selection criteria, which is followed by maintained regulations. Research shows that stem cell therapy as a treatment option is gaining popularity among healthcare professionals for mucopolysaccharidosis treatment, which can be attributed to the relation of its better reach towards a normal health condition for the patient.

Enzyme Replacement Therapy Remains Lucrative for Market Investors

As per further assessments of the mucopolysaccharidosis treatment market, it has been difficult to collect epidemiological data pertaining to rare diseases, especially mucopolysaccharidosis treatment, which is likely to impede the actual estimation of the economic burden associated with the condition. The cost estimation for each mucopolysaccharidosis treatment type is affecting and, in turn, creating a more vulnerable situation for the businesses and disrupting research & development activities for each company.

Enzyme replacement therapy is the most attractive segment for investors, however, the unavailability of reimbursement plans and precise treatment plans is encouraging most patient in developing regions to opt for symptomatic treatments instead of enzyme replacement therapy, which is still considered to be the standard mucopolysaccharidosis treatment.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5880

Key Players Focus on Clinical Research of Treatment Models

The report segments the mucopolysaccharidosis treatment market into seven regions to elaborate on the regional trends pertaining to the treatment plan. Major players are focusing on increasing their market share in the Asia Pacific market through strategic collaborations with regional research institutes. There is a lack of awareness about rare diseases among the general public as well as in medical healthcare facilities in several emerging economies. According to a survey and industry report, it takes patients in the US an average of 7.6 years and patients in the UK an average of 5.6 years to actually receive a proper diagnosis. Moreover, it involves a team of healthcare professionals to actually get the right mucopolysaccharidosis treatment and diagnosis pattern for reported cases.

Manufacturers are in the process of introducing a considerable number of mucopolysaccharidosis treatment options, which are currently under clinical trials. An estimated 160 and above clinical trials are being performed for mucopolysaccharidosis treatment. Thus, ensuring that the manufacturers take this mucopolysaccharidosis treatment market to be lucrative and potential rich in terms of revenue. Medical research institutes play an important role in this particular market. They are expected to be the bridge between treatment plans and economical solutions for manufacturers, thus leaving an explicable and lucrative model for mucopolysaccharidosis treatment.

The mucopolysaccharidosis treatment market includes companies such as BioMarin Takeda Pharmaceutical Company Limited, Sanofi S.A., and Ultragenyx Pharmaceutical Inc. BioMarin accounts for a significant value share in the present mucopolysaccharidosis treatment market. The currently existing promising drug types are expected to face competition from emerging candidates. In addition the mucopolysaccharidosis treatment products of other companies, such as Sangamo Therapeutics, Inc., REGENXBIO Inc., Sarepta Therapeutics, Abeona Therapeutics, Inc., and others, are also in the pipeline.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-5880

Mucopolysaccharidosis Treatment Market by Category

Treatment

  • Enzyme Replacement Therapies
  • Stem Cell Therapies
    • Bone Marrow Transplantation
    • Umbilical Cord Blood Transplantation

Type of MPS

  • MPS I
  • MPS II
  • MPS IV A
  • MPS VI
  • MPS VII

End User

  • Hospital
  • Specialty Clinics
  • Medical Research Centers
  • Home-infusion

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

 

Contact Us:

Future Market Insights
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedInTwitterBlogs

 

For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries:
press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Disposable Spinal Instruments Market is poised to increase at a robust CAGR of 8.3% between 2022 and 2028

Healthcare-Associated Infections or Hospital-Acquired Infections (HAIs) are caused while receiving medical treatment in a hospital facility. HAIs are among the major challenges to the safety of patients, and can have severe public health implications. These infections are also capable of causing disability and sometimes death. The occurrence of HAIs is increasing at an alarming rate. According to WHO, the prevalence of these infections in developed countries varies from 3.5% to 12%. Developing countries are at a higher risk as the rate of infection is 3-20 times higher in developing countries as compared to high-income countries.

In the U.S., more than 15 Mn surgeries are performed annually. Between 2% and 5% of patients are estimated develop a surgical site infection, which is between 160,000 and 300,000 surgical site infections nationwide each year. Surgical site infections are among the most commonly occurring HAIs in the U.S., and are the most expensive to treat. Fortunately, the adoption of various disposable devices and kits has reduced the incidence of surgical site infections and HAIs.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6890
Thus, the increasing preference for the usage of disposable instruments for reducing the occurrence of HAIs is driving the demand for disposable instruments, which is creating growth opportunities for the disposable spinal instruments market.

According to latest research by FMI, the global disposable spinal instruments market is  is estimated to be worth around US$ 59.7 Mn in 2022. Owing to the rise in hospital acquired infection cases, the overall demand for disposable spinal instruments is poised to increase at a robust CAGR of 8.3% between 2022 and 2028, totaling a valuation of US$ 96.5 Mn by 2028

The demand for disposable instruments kits in the healthcare industry is growing at a significant rate, and the demand from unconventional end-use industries is one of the major factors fuelling the market for disposable spinal instruments. Growth in the number of end users, apart from hospitals, such as orthopaedic clinics and Ambulatory Surgical Centres (ASCs), is expected to create high demand for disposable spinal instruments. Moreover, the adoption of disposable instrument kits by various end users has reduced the risk of infections and cross-contamination, which has resulted in a reduction in the number of HAIs.

Increase in the number of use cases of disposable spinal instruments in hospitals and ASCs is expected to boost the global demand for disposable instrument kits. According to CDC, the number of Medicare-certified ASCs has increased steadily from 239 in 1983 to 5,316 in 2010.

Moreover, increasing geriatric population, which is prone to various types of spinal injuries, is estimated to boost the need for surgeries. This is expected to contribute to the demand for disposable spinal instruments. The increasing requirement of instrument kits during surgeries among the greying population, coupled with improved life expectancy, has created significant growth opportunities for the manufactures of disposable spinal instruments market. However, factors such as stringent regulations and the generation of a significant amount of waste due to the usage of disposable kits is expected to lower the growth of disposable spinal instruments in the forecast period.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-6890

The disposable spinal instruments kits segment is a leading segment in terms of revenue by product type in the disposable spinal instruments market, with a 64.5% revenue share in 2021. These kits are most widely used in cervical and lumbar surgeries such as spinal fusion and decompression surgeries. Among the procedure type segments, the spinal fusion sub-segment accounts for the largest revenue share in the disposable spinal instruments market. Among all the end users in the disposable spinal instruments market, the hospitals sub-segment is expected to be a prominent segment, followed by the orthopaedic clinics sub-segment.

The disposable spinal instruments market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America, followed by Europe, is a prominent region in the global disposable spinal instruments market. North America accounted for a revenue share of 45.8% in 2021 in disposable spinal instruments market. Europe, accounting for the second-largest revenue share, is followed by East Asia in the disposable spinal instruments market. India, China, and Brazil are emerging markets in the disposable spinal instruments market. China is one of the fastest-growing emerging markets in the global disposable spinal instruments market, and is projected to grow at a CAGR of 11.2% over the forecast period of 2022-2029.

The disposable spinal instruments market report tracks some of the key companies operating in the disposable spinal instruments market, such as ECA Medical, Providence Medical Technology, Inc., Xenco Medical, Paradigm Spine, Intelligent Implant Systems, LLC, Safe Orthopaedics, SA , TeDan Surgical Innovations, LLC, and Joimax GmbH. Majority of the regional players in the disposable spinal instruments market are focused on increasing their product reach and connectivity with the regional distributors of disposable spinal instruments. The manufacturers of disposable spinal instruments are focusing on collaborating with established hospitals and ASCs to sell products as some of the medical practitioners are particular about the type and brand of products used for a surgical procedure.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-6890

Disposable Spinal Instruments Market by Category

By Product Type :

  • Instrument Kits
  • Cervical
  • Lumbar
  • Systems
By Procedure:
  • Spinal Fusion
  • Decompression Surgeries
By End User:
  • Hospitals
  • Orthopaedic Clinics
  • Ambulatory Surgical Centers
By Region:
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedInTwitterBlogs

 

For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries:
press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Isoprene Rubber Latex Market Trends 2021| Segmentation, Outlook, Industry Report to Register Growth at 8.1% CAGR Between 2021 – 2031

The global isoprene rubber latex market is anticipated to expand at 8.1% CAGR over the forecast period between 2021 and 2031, finds Future Market Insights (FMI) in a recent analysis. Increasing demand of medical gloves and condoms will continue driving the isoprene rubber latex sales. Growing utilization in medical and consumer goods industry will create conducive environment for the growth of the market in the coming years.

Rising demand of medical gloves in the healthcare industries due to growing awareness about health and safety measures to be employed to prevent the spread of diseases after COVID – 19 pandemics is propelling growth of the isoprene rubber latex market.

The increasing use of isoprene rubber latex in the manufacture of personal protective equipment and industrial items such as seals, gaskets, and conveyor belts is anticipated to be a major growth driver. The growing demand for customized industrial gloves is expected to bolster the sales in the market. In addition to this, application in condom manufacturing will strengthen sales prospects.

For Critical Insights, Request for PDF Sample – 

https://www.futuremarketinsights.com/reports/sample/rep-gb-7639

Key Takeaways:

  • Medical glove manufacturers are the predominant consumers of isoprene rubber latex. Medical gloves segment exhibited high demand following the COVID-19 outbreak.
  • Application in condom manufacturing will increasing, driving sales in the market.
  • Demand in the U.S. will grow year on year by 8.8% in 2021.
  • Demand in China will grow by 8.8% between 2021 and 2031.
  • Sales in Germany will account for 14.3% of overall consumption in Europe in 2021.

“Rising demand of medical gloves from healthcare industry and the increasing usage of adhesives in food, medical and industrial packaging will drive the market of isoprene rubber latex through the projected period from 2021 to 2031,” says a FMI analyst.

Competitive Landscape  

Key market participants in the global isoprene rubber latex market elaborated in the report includes Top Glove Corporation Bhd, Zeon Corporation, PAO Sibur Holdings, Kraton Corporation, Ansell Limited, Supermax Corp. Bhd, Royal Dutch Shell Plc, Kossan Rubber Industries Bhd, JSR Corporation, Hartalega Holdings Berhad, Rubberex Corporation, Johnson Wilshire, Medline Industries, Inc., Dipped Products Plc, Protective Industrial Products, Inc., and many others.

Key players operating in the global isoprene rubber latex market are focusing on increasing their production capacities to strengthen their footprint especially in the emerging economies. Furthermore, key market participants are focusing on mergers, acquisitions and collaborations strategies to expand their global presence and strengthen their distribution network. For instance:

  • In April 2018, Top Glove Corp Bhd acquired Aspion Sdn Bhd transforming the company into one of the world’s largest surgical glove maker and strengthening its position as the world’s largest glove manufacturer.

Isoprene Rubber Latex Market by Category

By Application:

  • Medical Gloves
  • Condoms
  • Medical Balloons
  • Catheters
  • Adhesives

By End Use:

  • Medical
  • Consumer Goods
  • Industrial

Get Customization in the Report, Enquire Now @ 

https://www.futuremarketinsights.com/customization-available/rep-gb-7639

Who is the Leading End User of Isoprene Rubber Latex?

Revenues generated in the medical segment is anticipated to grow by 10.6% year over year rate in 2021. Meanwhile, consumption for industrial gloves and adhesives production is expected to increase at 7.5% CAGR between 2020 and 2021.

Growing investment in the healthcare sector is expected to boost the isoprene rubber latex market in the coming years. Demand from tire and manufacturing industries for high tensile strength and good quality of tires also will fuel the demand for isoprene rubber in the coming years.

Read Related Report Links:

https://careero.mn.co/posts/22554061

https://www.diigo.com/item/note/9bws2/thqy?k=20eb44e46a2fd92fa4eb043159bf00cc

https://my-123.tumblr.com/post/681482986048323584/microcrystalline-cellulose-market-research-report

Contact Us

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedInTwitterBlogs

 

 

 

Decorative Plastic and Paper Laminates Market Report | Is Projected to Reach US$ 113 Bn by the End of 2028

In a recently released Future Market Insights outlook for decorative plastic and paper laminates, the global revenue is likely to observe moderate yearly growth in 2019 and approach US$ 70 Bn. “A majority of the sales of decorative plastic and paper laminates is attracted by a large number of smaller players operating in the competitive landscape. While more than half of the market value is accounted by the Tier 3 players that prominently include SMEs, a mere 10-15% share belongs to Tier 1 companies,” says a senior research analyst at the company.

Key Insights at a Glance

  • A third of the total market revenue is accounted by China, followed by Eastern Europe. FMI points to remarkable progress in sales of decorative plastic and paper laminates within BRICS countries.
  • Soaring demand for decorative foils and papers in the commercial sector is prominently responsible for superiority of low pressure laminates over high pressure counterparts.
  • As smaller players dominate the market, the strategic focus remains on product differentiation and cost competitive pricing. Reduced VOC emissions is another important factor dictating strategic moves of manufacturing SMEs.
  • Key players in decorative plastic and paper laminates landscape are currently concentrating on channelizing their efforts towards strengthening the distribution network, in addition to establish a direct sales channel.

Download Sample Copy of Report: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-7610

Rapid Recovery of Residential Housing Sector Firms up the Base for Decorative Plastic & Paper Laminates Demand

Although commercial sector currently dominates in terms of demand for decorative plastic and paper laminates, residential housing sector is likely to take over soon.

The residential construction realm has been witnessing strong signs of recovery over the past couple of years, which is playing a key driving force for the revenue growth of decorative plastic and paper laminates landscape.

Moreover, rapid growth of hospitality sector is providing a strong impetus to product innovation, thereby pushing the growth of leading bands dealing in decorative plastic and paper laminates landscape.

Commercial construction is also significantly favoring the sales decorative plastic and paper laminates, as indicated by the report.

Manufacturers of decorative plastic and paper laminates are also capitalizing on opportunities presented by a growing number of remodeling and repainting projects.

Wooden Flooring Trends among Consumers, Following Furniture & Cabinets

“Furniture and cabinets account for over half the share of total market value, whereas flooring applications are likely to gradually take over,” says the analyst.

Shifting consumer preferences for laminate flooring in both residential and commercial sectors is creating a heap of investment opportunities for manufacturers of decorative plastic and paper laminates.

“Consumers today seek endurance, scratch resistance, and aesthetics while purchasing furniture for homes or workplaces. Such factors are provide the trigger for application specific innovations in decorative plastic and paper laminates,” the analyst explains further.

Spectacular growth prospects are identified for Asia, North America and some parts of Eastern Europe.

Mushrooming Popularity of RTA Furniture Favors Global Sales of Decorative Plastic & Paper Laminates

Constant design innovation, consistent focus on superior quality, and maximum convenience are collectively driving consumer appeal for ready-to-assemble (RTA) furniture, especially in developed markets of North America and Europe.

Manufacturers of both RTA furniture and decorative plastic and paper laminates are taking efforts to collaboratively unlock the opportunities – with an additional benefit of less susceptibility to damage during transit and shipping.

Penetration of RTA furniture into developing economies is also gradually increasing owing to relatively lower price point and maintenance cost, thereby contributing to sales of decorative plastic and paper laminates.

Decorative Plastic and Paper Laminates Market: Segmentation

By Type

  • Low Pressure
  • High Pressure
  • Edge Banding

By Application

  • Furniture and Cabinets
  • Flooring
  • Wall Paneling
  • Doors
  • Column Cladding

By End Use

  • Residential
  • Commercial
  • Institutional

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • SEA
  • India
  • China
  • Japan
  • MEA

To remain ‘ahead’ of your competitors, get customized report – 

https://www.futuremarketinsights.com/customization-available/rep-gb-7610

Digital Print Designs on Decorative Plastic and Paper Laminates Gather Considerable Momentum

Personalization has been trending across industries, and interior decoration is among the prominent ones. Customized digitally printed laminates are especially designed to cater to specific consumer demands regarding print design, pattern, and graphic.

Sheets of digital decorative plastic and paper laminates have high resolution images printed on them, and can be directly applied on furniture, doors, commercials, exhibition stands, and walls.

Digital print laminates are creating a slew of opportunities for manufacturers in the decorative plastic and paper laminates landscape.

Read Related Report Links:

https://network-759413.mn.co/posts/22554056

https://shangwich.mn.co/posts/22554059

https://stemfemmes.mn.co/posts/global-microcrystalline-cellulose-market-by-system-type-by-end-user-by-region-industry-analysis-and-forecast-2022-2028

Contact Us

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedInTwitterBlogs

 

Coal Tar Pitch Market Report | Witness a Considerable CAGR of 5.4% During the Forecast Period of 2022 – 2028

Tier-1 companies in coal tar manufacturing represent 60-70% share of the total market revenue. With massive coal tar distillation capacities across the globe, these players in coal tar pitch landscape maintain their focus on both, standard grade and special grade coal tar pitch (CTP) production. Tier 2 players have a strong presence over restricted regions, whereas that of Tier 3 competitors is limited to regional sales. Standard grade coal tar pitch is the key focus area for the latter two, according to Future Market Insight’s study on the global coal tar pitch landscape.

“Production facility expansion, strategic acquisitions, and CTP product innovation will remain the key developmental strategies trending among leading players,” says a senior research analyst at FMI. The analyst adds further, “Massive Aluminum demand from automotive and transportation sectors has been pushing the Aluminum production levels 4-5% (yearly) since the recent past. Growing demand for lightweight vehicles is among the most impactful factors driving the consumption of Aluminum, subsequently contributing to sales of coal tar pitch”.

Long-term Contractual Partnerships & Backward Integrated Supply Rule Strategic Minds of Coal Tar Pitch Manufacturers

While manufacturers of coal tar pitch are preferring long-term supply contracts with leading coal tar manufacturers, FMI has also identified these players entering strategic partnerships with steel manufacturers, where coal tar is often the byproduct of coke processing ovens. A few other activities that make this landscape dynamic include long-term contracts between manufacturers of coal tar pitch and those of primary aluminum and graphite electrode, with a sole objective to sustain the coal tar pitch supply to end markets.

Request a report sample to gain comprehensive insights at@ 

https://www.futuremarketinsights.com/reports/sample/rep-gb-7186

Aluminum Grade CTP Holds a Winning Revenue Share in Coal Tar Pitch Market

Application-wise, around 80% revenue share belongs to the aluminum electrode, according to the study. As coal tar pitch is increasingly being consumed by aluminum smelters lowing to higher sustainability and economic feasibility, the mushrooming Aluminum production is constantly driving the growth of coal tar pitch landscape. In 2019, the revenue of Aluminum grade coal tar pitch is pegged for over 5% Y-o-Y growth. Besides, Graphite electrode is also slated for promising performance and the application base of coal tar pitch as a chemical intermediate in carbon black manufacturing is visibly growing.

Development of Specialized ‘Zero QI Impregnating’ Coal Tar Pitch Expands Applicability

A specialized ‘impregnating’ pitch obtained by processing coal tar at a high temperature is widely used in the Graphite industry during the electrode manufacturing process. The resultant technological advancements in the life of electrodes pushes CTP applications in roofing, coating, electrode, refractory, and others.

China Commands over Global Coal Tar Pitch Landscape, India Leads Asia Pacific’s CTP Scenario

China, India, Russia, and Western Europe have a significant aluminum production base, whereas MEA is demonstrating promising growth in coal tar pitch landscape in recent years. North America, however, is observing passive growth over the recent past, post decline in the aluminum production levels.

According to the FMI’s report, China is the global leader in coal tar pitch ecosystem owing to significant Aluminum production and thriving production levels of Graphite electrode. China is projected for a 6% year on year revenue growth by this year’s end, reflecting ample growth opportunities for coal tar pitch manufacturers.

On the other side, APAC’s market for coal tar pitch is witnessing growth concentration in India that has been attributed to an impressive rate of Aluminum production in the country.

Coal Tar Pitch Market Market by Category

By Form:

  • Solid
  • Liquid

By Grade:

  • Aluminum Grade
  • Graphite Grade
  • Special Grade

By Application:

  • Aluminum Electrode
  • Graphite Electrode
  • Roofing Coating Material
  • Blast Furnance Linings
  • Chemical Intermediates
  • Sealents

By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • APEC (Asia Pacific Excluding China)
  • China
  • Middle East & Africa

Ask for Customization: 

https://www.futuremarketinsights.com/customization-available/rep-gb-7186

Competitive Landscape

Over the past few years, manufacturers are shifting their focus towards emerging regions to cater the growing demand from the application segments. Several key players are also focusing on expanding their production capacities, product launches, R & D and are also focusing on mergers & acquisition.

For Instance,

In 2017, Koppers Inc., a wholly-owned subsidiary of Koppers Holdings Inc., announced its new long-term coal tar supply agreement with leading steelmaker ArcelorMittal.

In 2018, Himadri Specialty Chemicals Ltd announced its plan to expand its production facility at Singur in West Bengal by making a planned investment of Rs 1,000 crore over the next five years.

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis is available in the report.

Read Related Report Links:

https://theastuteparent.tribe.so/post/microcrystalline-cellulose-market-trends-2022-segmentation-outlook-industry–6257abca072e63248b803dbb

https://immigrationsociety.tribe.so/post/microcrystalline-cellulose-market-trends-2022-segmentation-outlook-industry–6257abcb178b1b3836696d8e

https://cipmo-system.mn.co/posts/22554055

Contact Us

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedInTwitterBlogs

 

Plywood Market Key Players, End User, Demand and Consumption by to Register a CAGR of 6.1% to Reach a Valuation of US$ 115 Bn by 2028

Future Market Insights (FMI) throws light on some of the key factors boosting revenues in the global market for plywood. Plywood finds increasing use across diverse applications ranging from furniture, flooring, and packaging of high-value goods. This is anticipated to boost sales of plywood in the global market, according to Future Market Insights forecasts. A growth in residential and commercial spaces across the world has further boosted the demand for readymade and aesthetically designed furniture, incorporating extensive use of plywood. With people opting for designer furniture, the demand for plywood from the furniture industry is already peaking and this is anticipated to augment revenues in the global plywood market.

Global infrastructural development has reached newer heights in the last few years, with massive constructions – both residential and commercial – mushrooming across both Tier 1 and Tier 2 cities across the world. This has led to impressive growth of the global building and construction industry and as a consequence positively impacted revenues of ancillary industries. Plywood is an inherent component of the construction industry – being widely used in manufacturing readymade and customised furniture.

“Growth in global consumption of plywood is pegged to increase at a decadal rate of 4.6% to reach 164,402 cubic meters by the end of 2022. This growth is attributable to the continuous demand from end-use industries especially the furniture production industry.” — Future Market Insights

For Critical Insights, Request for PDF Sample – 

https://www.futuremarketinsights.com/reports/sample/rep-gb-3463

Besides, there is an increasing global phenomena promoting the use of wood and wood based products in the construction of both residential as well as commercial buildings. This trend is being supported by laws enforced at the administrative level. For instance, Japan’s “Act for Promotion of Use of Wood Products in Public Buildings, 2010” seeks to encourage the use of plywood in the construction sector. Global construction projects focusing on wooden skyscrapers such as the Oakwood Timber Tower are also expected to positively impact demand for plywood in the coming years.

Wood and wood based products such as plywood are eco-friendly in nature, encouraging the plantation of trees to meet the rising demand. Plywood and other ancillary wood products contribute to environmental protection. This is another factor acting in favour of the plywood market.

This study by FMI on the plywood market further identifies the growing importance of plywood in the global packaging industry as a key demand driver. “Plywood has enhanced mechanical strength besides being lightweight in nature. Plywood is also reusable and helps save on costs. This makes plywood the best packaging option for various types of products. With the current ban on plastic for product packaging, plywood is being increasingly adopted as a highly effective raw material to package different types of goods. This is expected to boost revenues in the global plywood market.”

Lucrative Opportunities Lie in the African Timberlands for both Existing Players and New Market Entrants

The presence of vast expanses of land in Africa coupled with the overall low costs of maintenance and production in the region make Africa a very attractive choice for the growth of forestry and the manufacturing of wood products, particularly plywood. Manufacturers in the global plywood market are looking at lucrative growth prospects in the African continent, given the region’s huge natural timberlands and mature plantations. Harvesting of plywood in the African forests is both cost-effective and environment friendly. This is boosting the setting up of backward integrated units manufacturing plywood, hence creating highly lucrative opportunities for players in the global plywood market.

Massive growth of the global construction industry has resulted in the pumping in of huge infrastructure investments by both private sector and public sector enterprises. This is likely to broaden the horizon for regional manufacturers of plywood with endless possibilities for revenue growth.

To remain ‘ahead’ of your competitors, get customized report – 

https://www.futuremarketinsights.com/customization-available/rep-gb-3463

Adoption of Plywood in Digital Printing Trending the Global Market

Plywood is increasingly finding application as a substrate in high-scale inkjet printing projects. Plywood is used as an alternative to aluminium and plastic sheets owing to its non-reflective nature. Digitally printed plywood serves as an excellent substitute for several outdoor applications such as fence and road signs, as it is highly durable. This is the latest trend dotting the global plywood landscape, pushing revenues in the global market.

Read Related Report Links:

https://rigenrin.tribe.so/post/microcrystalline-cellulose-market-worldwide-industry-analysis-and-new-marke–6257abbca86f3b11953b879f

https://sharequant.tribe.so/post/microcrystalline-cellulose-market-worldwide-industry-analysis-and-new-marke–6257abbe45af6b7a0440d2bb

https://itsthesa.tribe.so/post/microcrystalline-cellulose-market-trends-2022-segmentation-outlook-industry–6257abc3e05a20e860f16bb7

Contact Us

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedInTwitterBlogs